Literature DB >> 15151791

[Efficacy of an intervention to improve treatment compliance in hyperlipidemias].

E Márquez Contreras1, J J Casado Martínez, Y Corchado Albalat, R Chaves González, A Grandío, C Losada Velasco, J Obando, J M de Eugenio, J M Barrera.   

Abstract

OBJECTIVE: To analyse the efficacy of the intervention through a telephone call about patients' compliance with lipaemia therapy.
DESIGN: Controlled, randomised clinical trial.
SETTING: Ten clinics at 6 primary care centres. PARTICIPANTS: 126 people diagnosed with hypercholesterolaemia according to Spanish Consensus criteria were chosen. INTERVENTION: Two groups were formed. The control group (CG) of 63 patients, who received the doctor's normal treatment; and the Intervention group (IG) of 63 patients, who received in addition a telephone call at 2 weeks, 2 months and 4 months. MAIN MEASUREMENTS: Pills were counted and cholesterol, triglycerides, HDL-C and LDL-C determined at the start, and at the third and sixth months. Percentages of patients complying (80%-110%), the mean compliance percentage and the degree of control were compared. The reduction of absolute and relative risk (RAR and RRR) and the mean number of people that required an intervention in order to avoid non-compliance (NI) were calculated.
RESULTS: 115 people (91.26%) completed the survey, 56 in the IG and 59 in the CG. 77.1% complied with the therapy (CI, 68.4-85.8), (CG=64.4%, CI, 55.3-73.5; IG=93.5%, CI, 88.8-98 [P<.001]). Mean compliance ran at 88.7 +/- 10.2 overall, at 84.4 +/- 12.8 in the CG and at 93 +/- 8.2 in the IG (P<.001). The RAR was 29.1%, the RRR 81%, and the NI was 3.43 patients. The patients controlled ran at 43.9% in the IG (CI, 34.9-52.9) and 23.1% in the CG (CI, 15.4-30.8) (P<.005).
CONCLUSIONS: The telephone intervention is an efficacious way of improving the percentage of patients complying with lipaemia treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15151791     DOI: 10.1016/s0212-6567(04)79430-5

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  10 in total

1.  [One more tool to improve therapeutic compliance].

Authors:  Carme Batalla Martínez
Journal:  Aten Primaria       Date:  2009-03-25       Impact factor: 1.137

Review 2.  Interventions for enhancing medication adherence.

Authors:  Robby Nieuwlaat; Nancy Wilczynski; Tamara Navarro; Nicholas Hobson; Rebecca Jeffery; Arun Keepanasseril; Thomas Agoritsas; Niraj Mistry; Alfonso Iorio; Susan Jack; Bhairavi Sivaramalingam; Emma Iserman; Reem A Mustafa; Dawn Jedraszewski; Chris Cotoi; R Brian Haynes
Journal:  Cochrane Database Syst Rev       Date:  2014-11-20

Review 3.  Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventions.

Authors:  J L Marcus; T Buisker; T Horvath; K R Amico; J D Fuchs; S P Buchbinder; R M Grant; A Y Liu
Journal:  HIV Med       Date:  2014-02-24       Impact factor: 3.180

Review 4.  A Metaanalysis of Interventions to Improve Adherence to Lipid-Lowering Medication.

Authors:  Richard E Deichmann; Michael D Morledge; Robin Ulep; Johnathon P Shaffer; Philippa Davies; Mieke L van Driel
Journal:  Ochsner J       Date:  2016

5.  Factors Associated with Medication Non-adherence in Patients with End-Stage Liver Disease.

Authors:  Selena Z Kuo; Marta Haftek; Jennifer C Lai
Journal:  Dig Dis Sci       Date:  2016-12-08       Impact factor: 3.199

6.  Effectiveness of Motivational Interviewing in improving lipid level in patients with dyslipidemia assisted by general practitioners: Dislip-EM study protocol.

Authors:  Luis A Pérula; Josep M Bosch; Julia Bóveda; Manuel Campiñez; Nieves Barragán; Juan C Arboniés; Jose A Prados; Enrique Martín; Remedios Martín; Josep Massons; Margarita Criado; Roger Ruiz; José A Fernández; Francisco Buitrago; Inmaculada Olaya; Modesto Pérez; Joaquin Ruiz
Journal:  BMC Fam Pract       Date:  2011-11-05       Impact factor: 2.497

7.  Effectiveness of a combined strategy to improve therapeutic compliance and degree of control among patients with hypercholesterolaemia: a randomised clinical trial.

Authors:  Ignacio Párraga-Martínez; Joseba Rabanales-Sotos; Fernando Lago-Deibe; Juan M Téllez-Lapeira; Francisco Escobar-Rabadán; Alejandro Villena-Ferrer; Mariano Blasco-Valle; José M Ferreras-Amez; Susana Morena-Rayo; José M del Campo-del Campo; Maria Candelaria Ayuso-Raya; José J Pérez-Pascual
Journal:  BMC Cardiovasc Disord       Date:  2015-01-19       Impact factor: 2.298

Review 8.  Improving medication adherence in hypercholesterolemia: challenges and solutions.

Authors:  Justin Gatwood; James E Bailey
Journal:  Vasc Health Risk Manag       Date:  2014-11-06

9.  Using qualitative evidence on patients' views to help understand variation in effectiveness of complex interventions: a qualitative comparative analysis.

Authors:  Bridget Candy; Michael King; Louise Jones; Sandy Oliver
Journal:  Trials       Date:  2013-06-18       Impact factor: 2.279

10.  Effectiveness of motivational interviewing in patients with dyslipidemia: a randomized cluster trial.

Authors:  Julia Bóveda-Fontán; Nieves Barragán-Brun; Manuel Campiñez-Navarro; Luís Ángel Pérula-de Torres; Josep M Bosch-Fontcuberta; Remedios Martín-Álvarez; Juan Carlos Arbonies-Ortiz; Jesús Manuel Novo-Rodríguez; Margarita Criado-Larumbe; Jose Angel Fernández-García; Enrique Martín-Rioboó
Journal:  BMC Fam Pract       Date:  2015-10-24       Impact factor: 2.497

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.